This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Melillo, L., Sajeva, M., Musto, P. et al. Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer. Leukemia 11, 2211–2213 (1997). https://doi.org/10.1038/sj.leu.2400876
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400876
This article is cited by
-
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients
Bone Marrow Transplantation (2003)
-
Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities
Leukemia (2002)